Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy

Epigenetics

Volumn 6, Issue 7, 2011, Pages 928-936

  Hoyo, Cathrine ^a   Murtha, Amy P ^b   Schildkraut, Joellen M ^a   Jirtle, Randy ^c   Demark Wahnefried, Wendy ^d   Forman, Michele R ^d   Iversen, Edwin S ^c   Kurtzberg, Joanne ^c   Overcash, Francine ^a   Huang, Zhiqing ^c   Murphy, Susan K ^c  

^a Department of Community and Family Medicine   (United States)

^b Department of Obstetrics and Gynecology   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Epigenetics; Exposure; Folic acid; IGF2; Periconception; Prenatal

Indexed keywords

FOLIC ACID; SOMATOMEDIN B;

ADULT; ARTICLE; CHRONIC DISEASE; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; DNA METHYLATION; FEMALE; HEALTH SURVEY; HUMAN; MATERNAL BEHAVIOR; MATERNAL NUTRITION; PREPREGNANCY CARE; PROTEIN EXPRESSION; PYROSEQUENCING; REGULATORY MECHANISM; UMBILICAL CORD BLOOD;

EID: 79960150663     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.7.16263     Document Type: Article

References (71)

1. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999; 341:1485-1490.
2. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327:1832-1835.
3. Effectiveness in Disease and Injury Prevention Use of Folic Acid for Prevention of Spina Bifida and Other Neural Tube Defects -1983-1991. In: Control CfD, ed. MMWR Morb Mortal Wkly Rep Atlanta: Centers for Disease Control, 1991.
4. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991; 338:131-137.
5. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001; 285:2981-2986.
6. US IoM. Institute of Medicine. Dietary reference intakes from thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, patothenic acid, biotin and choline. Washington, DC: National Academy Press, 1998.
7. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006; 38:90-6.
8. US Food and Drug Administration. Food Standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Federal Register 1996; 61:8781-97.
9. Yang QH, Carter HK, Mulinare J, Berry RJ, Friedman JM, Erickson JD. Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001-2002. Am J Clin Nutr 2007; 85:1409-1416.
10. Crane NT, Wilson DB, Cook DA, Lewis CJ, Yetley EA, Rader JI. Evaluating food fortification options: general principles revisited with folic acid. Am J Public Health 1995; 85:660-666.
11. Carmichael SL, Shaw GM, Yang W, Laurent C, Herring A, Royle MH, et al. Correlates of intake of folic acid-containing supplements among pregnant women. Am J Obstet Gynecol 2006; 194:203-210.
12. George L, Mills JL, Johansson AL, Nordmark A, Olander B, Granath F, et al. Plasma folate levels and risk of spontaneous abortion. JAMA 2002; 288: 1867-1873.
13. Wen SW, Chen XK, Rodger M, White RR, Yang Q, Smith GN, et al. Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol 2008; 198:45 e1-7.
14. Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA. Risk of gestational hypertension in relation to folic acid supplementation during pregnancy. Am J Epidemiol 2002; 156:806-812.
15. Godwin KA, Sibbald B, Bedard T, Kuzeljevic B, Lowry RB, Arbour L. Changes in frequencies of select congenital anomalies since the onset of folic acid fortification in a Canadian birth defect registry. Can J Public Health 2008; 99:271-275.
16. Haberg SE, London SJ, Stigum H, Nafstad P, Nystad W. Folic acid supplements in pregnancy and early childhood respiratory health. Arch Dis Child 2009; 94:180-184.
17. Whitrow MJ, Moore VM, Rumbold AR, Davies MJ. Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am J Epidemiol 2009; 170:1486-1493.
18. Hollingsworth JW, Maruoka S, Boon K, Garantziotis S, Li Z, Tomfohr J, et al. In utero supplementation with methyl donors enhances allergic airway disease in mice. J Clin Invest 2008; 118:3462-3469.
19. Ulrich CM. Folate and cancer prevention: a closer look at a complex picture. Am J Clin Nutr 2007; 86:271-273.
20. Yang Q, Bostick RM, Friedman JM, Flanders WD. Serum folate and cancer mortality among U.S. adults: findings from the Third National Health and Nutritional Examination Survey linked mortality file. Cancer Epidemiol Biomarkers Prev 2009; 18:1439-1447.
21. Smith AD, Kim YI, Refsum H. Is folic acid good for everyone? Am J Clin Nutr 2008; 87:517-533.
22. Barker DJ. Developmental origins of adult health and disease. J Epidemiol Community Health 2004; 58: 114-115.
23. Depeint F, Bruce WR, Shangari N, Mehta R, O'Brien PJ. Mitochondrial function and toxicity: role of B vitamins on the one-carbon transfer pathways. Chem Biol Interact 2006; 163:113-132.
24. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 2003; 23:5293-5300.
25. Murphy SK, Jirtle RL. Imprinting evolution and the price of silence. BioEssays 2003; 25:577-588.
26. Woodfine K, Huddleston JE, Murrell A. Quantitative analysis of DNA methylation at all human imprinted regions reveals preservation of epigenetic stability in adult somatic tissue. Epigenetics Chromatin; 4:1.
27. Waterland RA, Kellermayer R, Laritsky E, Rayco-Solon P, Harris RA, Travisano M, et al. Season of conception in rural gambia affects DNA methylation at putative human metastable epialleles. PLoS Genet; 6:e1001252.
28. Edwards CA, Rens W, Clarke O, Mungall AJ, Hore T, Graves JA, et al. The evolution of imprinting: chromosomal mapping of orthologues of mammalian imprinted domains in monotreme and marsupial mammals. BMC Evol Biol 2007; 7:157.
29. Varrault A, Gueydan C, Delalbre A, Bellmann A, Houssami S, Aknin C, et al. Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth. Dev Cell 2006; 11:711-722.
30. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003; 299:1753-1755.
31. Cruz-Correa M, Cui H, Giardiello FM, Powe NR, Hylind L, Robinson A, et al. Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology 2004; 126:964-970.
32. Cruz-Correa M, Zhao R, Oviedo M, Bernabe RD, Lacourt M, Cardona A, et al. Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene. Epigenetics 2009; 4.
33. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 2008; 105:17046-17049.
34. Steegers-Theunissen RP, Obermann-Borst SA, Kremer D, Lindemans J, Siebel C, Steegers EA, et al. Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS One 2009; 4:e7845.
35. Hoyo C, Murtha AP, Schildkraut JM, Forman MR, Calingaert B, Demark-Wahnefried W, et al. Folic acid supplementation before and during pregnancy in the Newborn Epigenetics Study (NEST). BMC Public Health 2011; 11:46.
36. Huang Z, Wen Y, Shandilya R, Marks JR, Berchuck A, Murphy SK. High throughput detection of M6P/ IGF2R intronic hypermethylation and LOH in ovarian cancer. Nucleic Acids Res 2006; 34:555-563.
37. Murphy SK, Huang Z, Wen Y, Spillman MA, Whitaker RS, Simel LR, et al. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer. Mol Cancer Res 2006; 4: 283-292.
38. Xu W, Fan H, He X, Zhang J, Xie W. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR. J Exp Clin Cancer Res 2006; 25:543-547.
39. Murrell A, Ito Y, Verde G, Huddleston J, Woodfine K, Silengo MC, et al. Distinct methylation changes at the IGF2-H19 locus in congenital growth disorders and cancer LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR. PLoS One 2008; 3:e1849.
40. Cui H, Niemitz EL, Ravenel JD, Onyango P, Brandenburg SA, Lobanenkov VV, et al. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site. Cancer Res 2001; 61:4947-4950.
41. Cui H, Onyango P, Brandenburg S, Wu Y, Hsieh CL, Feinberg AP. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 2002; 62:6442-6446.
42. Nakagawa H, Chadwick RB, Peltomaki P, Plass C, Nakamura Y, de La Chapelle A. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19-associated CTCFbinding sites in colorectal cancer. Proc Natl Acad Sci USA 2001; 98:591-596.
43. Sullivan MJ, Taniguchi T, Jhee A, Kerr N, Reeve AE. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation. Oncogene 1999; 18:7527-7534.
44. Takai D, Gonzales FA, Tsai YC, Thayer MJ, Jones PA. Large scale mapping of methylcytosines in CTCFbinding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. Hum Mol Genet 2001; 10:2619-2626.
45. Wong HL, Byun HM, Kwan JM, Campan M, Ingles SA, Laird PW, et al. Rapid and quantitative method of allele-specific DNA methylation analysis. Biotechniques 2006; 41:734-739.
46. Kerkel K, Spadola A, Yuan E, Kosek J, Jiang L, Hod E, et al. Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet 2008; 40:904-908.
47. Richards EJ. Inherited epigenetic variation--revisiting soft inheritance. Nat Rev Genet 2006; 7:395-401.
48. Hoyo C, Murphy SK, Jirtle RL. Imprint regulatory elements as epigenetic biosensors of exposure in epidemiological studies. J Epidemiol Community Health 2009; 63:683-684.
49. Heijmans BT, Tobi EW, Lumey LH, Slagboom PE. The epigenome: archive of the prenatal environment. Epigenetics 2009; 4:526-531.
50. Mathers JC. Early nutrition: impact on epigenetics. Forum Nutr 2007; 60:42-48.
51. Bell AAC, Felsenfeld GG. Methylation of a CTCFdependent boundary controls imprinted expression of the Igf2 gene. Nature 2000; 405:482-485.
52. Kanduri C, Holmgren C, Pilartz M, Franklin G, Kanduri M, Liu L, et al. The 5' flank of mouse H19 in an unusual chromatin conformation unidirectionally blocks enhancer-promoter communication. Curr Biol 2000; 10:449-457.
53. Ulaner GAGA, Vu THTH, Li TT, Hu JFJ-F, Yao XMX-M, Yang YY, et al. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site. Hum Mol Genet 2003; 12:535-549.
54. Nakagawa HH, Chadwick RRB, Peltomaki PP, Plass CC, Nakamura YY, de La Chapelle AA. Loss of imprinting of the insulin-like growth factor II gene occurs by biallelic methylation in a core region of H19- associated CTCF-binding sites in colorectal cancer. Proc Natl Acad Sci USA 2001; 98:591-596.
55. Gomes MV, Waterland RA. Individual epigenetic variation: when, why, and so what? Nestle Nutr Workshop Ser Pediatr Program 2008; 62:141-150; discussion 151-5.
56. Waterland RA. Do maternal methyl supplements in mice affect DNA methylation of offspring? J Nutr 2003; 133:238; author reply 9.
57. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 1998; 68:899-917.
58. Ravelli GP, Stein ZA, Susser MW. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med 1976; 295:349-353.
59. Ravelli AC, van Der Meulen JH, Osmond C, Barker DJ, Bleker OP. Obesity at the age of 50 y in men and women exposed to famine prenatally. Am J Clin Nutr 1999; 70:811-816.
60. Elias SG, Peeters PH, Grobbee DE, van Noord PA. Breast cancer risk after caloric restriction during the 1944-1945 Dutch famine. J Natl Cancer Inst 2004; 96:539-546.
61. Elias SG, Onland-Moret NC, Peeters PH, Rinaldi S, Kaaks R, Grobbee DE, et al. Urinary endogenous sex hormone levels in postmenopausal women after caloric restriction in young adulthood. Br J Cancer 2004; 90:115-117.
62. Barker DJ. The developmental origins of adult disease. J Am Coll Nutr 2004; 23:588S-95S.
63. Gluckman P, Hanson M, Beedle A. Early life events and their consequences for later disease: A life history and evolutionary perspective. Am J Hum Biol 2007; 19.
64. Painter RC, Roseboom TJ, Bleker OP. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol 2005; 20:345-352.
65. Yajnik CS. Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries. J Nutr 2004; 134:205-210.
66. Takano Y, Shiota G, Kawasaki H. Analysis of genomic imprinting of insulin-like growth factor 2 in colorectal cancer. Oncology 2000; 59:210-216.
67. Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007; 8: 253-262.
68. Feinberg AP. An epigenetic approach to cancer etiology. Cancer J 2007; 13:70-74.
69. D'Angelo D, Williams L, Morrow B, Cox S, Harris N, Harrison L, et al. Preconception and interconception health status of women who recently gave birth to a live-born infant--Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004. MMWR Surveill Summ 2007; 56:1-35.
70. Jasti S, Siega-Riz AM, Cogswell ME, Hartzema AG, Bentley ME. Pill count adherence to prenatal multivitamin/ mineral supplement use among low-income women. J Nutr 2005; 135:1093-1101.
71. Vollset SE, Gjessing HK, Tandberg A, Ronning T, Irgens LM, Baste V, et al. Folate supplementation and twin pregnancies. Epidemiology 2005; 16:201-205.